Alzheimer's & dementia (New York, N. Y.) - JoVE Visualize

Showing results (501-510 of 1,063) with videos related to

Pageof 107

Sort By:

Alzheimer'S & Dementia (New York, N. Y.)|September 11, 2024

Anti-epileptic drug use and subsequent degenerative dementia occurrenceNaoki Ikegaya, Honoka Nakamura, Yutaro Takayama, et al.

Alzheimer'S & Dementia (New York, N. Y.)|May 30, 2023

Inclusion of Vietnamese Americans: Opportunities to understand dementia disparitiesOanh L Meyer, Van Ta Park, Alka M Kanaya, et al.

Alzheimer'S & Dementia (New York, N. Y.)|December 20, 2017

Integrating sex and gender into neurodegeneration research: A six-component strategyMary C Tierney, Ashley F Curtis, Howard Chertkow, et al.

Alzheimer'S & Dementia (New York, N. Y.)|February 25, 2026

Correction to "Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study"

Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026

Physical activity attenuates the association between allostatic load and early Alzheimer's disease-related biomarkers in older adultsGéraldine Poisnel, Mathilde Lhérault, Cassandre Palix, et al.

Alzheimer'S & Dementia (New York, N. Y.)|April 20, 2026

Neuroprotection trial design in progressive supranuclear palsy: challenges and solutionsLawrence I Golbe, Ronald G Thomas

Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026

Economic evaluations of strategies targeting pre-diagnosis dementia populations: A systematic reviewMen Thi Hoang, Alina Mona Zenker, Sanjib Saha, et al.

Alzheimer'S & Dementia (New York, N. Y.)|March 8, 2021

Population measures of subjective cognitive decline: A means of advancing public health policy to address cognitive healthBenjamin S Olivari, Matthew Baumgart, Christopher A Taylor, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 3, 2023

Dementia care navigation: Building toward a common definition, key principles, and outcomesBeth A Kallmyer, David Bass, Matthew Baumgart, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 23, 2026

Six-month real-world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementiaGeon Ha Kim, Hai-Jeon Yoon, Eun Hee Kim, et al.

Pageof 107

Showing results (501-510 of 1,063) with videos related to

Sort By:

Pageof 107

Alzheimer'S & Dementia (New York, N. Y.)|September 11, 2024

Anti-epileptic drug use and subsequent degenerative dementia occurrenceNaoki Ikegaya, Honoka Nakamura, Yutaro Takayama, et al.

Alzheimer'S & Dementia (New York, N. Y.)|May 30, 2023

Inclusion of Vietnamese Americans: Opportunities to understand dementia disparitiesOanh L Meyer, Van Ta Park, Alka M Kanaya, et al.

Alzheimer'S & Dementia (New York, N. Y.)|December 20, 2017

Integrating sex and gender into neurodegeneration research: A six-component strategyMary C Tierney, Ashley F Curtis, Howard Chertkow, et al.

Alzheimer'S & Dementia (New York, N. Y.)|February 25, 2026

Correction to "Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study"

Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026

Physical activity attenuates the association between allostatic load and early Alzheimer's disease-related biomarkers in older adultsGéraldine Poisnel, Mathilde Lhérault, Cassandre Palix, et al.

Alzheimer'S & Dementia (New York, N. Y.)|April 20, 2026

Neuroprotection trial design in progressive supranuclear palsy: challenges and solutionsLawrence I Golbe, Ronald G Thomas

Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026

Economic evaluations of strategies targeting pre-diagnosis dementia populations: A systematic reviewMen Thi Hoang, Alina Mona Zenker, Sanjib Saha, et al.

Alzheimer'S & Dementia (New York, N. Y.)|March 8, 2021

Population measures of subjective cognitive decline: A means of advancing public health policy to address cognitive healthBenjamin S Olivari, Matthew Baumgart, Christopher A Taylor, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 3, 2023

Dementia care navigation: Building toward a common definition, key principles, and outcomesBeth A Kallmyer, David Bass, Matthew Baumgart, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 23, 2026

Six-month real-world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementiaGeon Ha Kim, Hai-Jeon Yoon, Eun Hee Kim, et al.

Pageof 107